OLANZAPINE IN THE TREATMENT OF SCHIZOPHRENIA : AN OPEN LABEL COMPARATIVE CLINICAL TRIAL FROM NORTH INDIA

The aim of the present study was to assess the efficacy and safety of olanzapine in the treatment of schizophrenic patients. 27 patients were randomly assigned to treatment with olanzapine or haloperidol over 12 weeks. The primary efficacy measure was the mean change from baseline to endpoint in tot...

Descripción completa

Detalles Bibliográficos
Autores principales: Avasthi, Ajit, Kulhara, Parmanand, Kakkar, Neeraj
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2001
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956152/
https://www.ncbi.nlm.nih.gov/pubmed/21407865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956152/
https://www.ncbi.nlm.nih.gov/pubmed/21407865

Ejemplares similares